Showing results (991-1000 of 3,507) with videos related to

Sort By:
Pageof 351
Eclinicalmedicine|February 16, 2022
Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysisRachel Harwood, Helen Yan, Nishanthi Talawila Da Camara, et al.
Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
Eclinicalmedicine|July 28, 2022
Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approachArindam Nandi, Nathaniel Counts, Simiao Chen, et al.
Eclinicalmedicine|July 28, 2022
Mitigating the mental health consequences of mass shootings: An in-silico experimentSalma M Abdalla, Gregory H Cohen, Shailesh Tamrakar, et al.
Eclinicalmedicine|October 6, 2021
Rectal bacteriome and virome signatures and clinical outcomes in community-acquired pneumonia: An exploratory studyRobert F J Kullberg, Floor Hugenholtz, Xanthe Brands, et al.
Eclinicalmedicine|October 6, 2021
Ethnicity and acute hospital admissions: Multi-center analysis of routine hospital dataYize I Wan, Alexander J Robbins, Vanessa J Apea, et al.
Eclinicalmedicine|October 6, 2021
Serum ω-6/ω-3 polyunsaturated fatty acids ratio and diabetic retinopathy: A propensity score matching based case-control study in ChinaShuzhen Zhao, Dongzhen Jin, Shengyao Wang, et al.
Eclinicalmedicine|October 11, 2021
Multidimensional and intergenerational impact of Severe Mental DisordersWubalem Fekadu, Tom K J Craig, Derege Kebede, et al.
Eclinicalmedicine|October 5, 2021
An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in VietnamNguyen Van Vinh Chau, Nghiem My Ngoc, Lam Anh Nguyet, et al.
Eclinicalmedicine|April 18, 2022
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)Francisco Hernández-Bernal, Maria C Ricardo-Cobas, Yenima Martín-Bauta, et al.
Pageof 351